Cargando…

Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient

Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing d...

Descripción completa

Detalles Bibliográficos
Autores principales: Princiotta Cariddi, Lucia, Tabaee Damavandi, Payam, Carimati, Federico, Banfi, Paola, Clemenzi, Alessandro, Marelli, Margherita, Giorgianni, Andrea, Vinacci, Gabriele, Mauri, Marco, Versino, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312113/
https://www.ncbi.nlm.nih.gov/pubmed/32583053
http://dx.doi.org/10.1007/s00415-020-10001-7
_version_ 1783549659868823552
author Princiotta Cariddi, Lucia
Tabaee Damavandi, Payam
Carimati, Federico
Banfi, Paola
Clemenzi, Alessandro
Marelli, Margherita
Giorgianni, Andrea
Vinacci, Gabriele
Mauri, Marco
Versino, Maurizio
author_facet Princiotta Cariddi, Lucia
Tabaee Damavandi, Payam
Carimati, Federico
Banfi, Paola
Clemenzi, Alessandro
Marelli, Margherita
Giorgianni, Andrea
Vinacci, Gabriele
Mauri, Marco
Versino, Maurizio
author_sort Princiotta Cariddi, Lucia
collection PubMed
description Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2.
format Online
Article
Text
id pubmed-7312113
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73121132020-06-24 Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient Princiotta Cariddi, Lucia Tabaee Damavandi, Payam Carimati, Federico Banfi, Paola Clemenzi, Alessandro Marelli, Margherita Giorgianni, Andrea Vinacci, Gabriele Mauri, Marco Versino, Maurizio J Neurol Letter to the Editors Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2. Springer Berlin Heidelberg 2020-06-24 2020 /pmc/articles/PMC7312113/ /pubmed/32583053 http://dx.doi.org/10.1007/s00415-020-10001-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editors
Princiotta Cariddi, Lucia
Tabaee Damavandi, Payam
Carimati, Federico
Banfi, Paola
Clemenzi, Alessandro
Marelli, Margherita
Giorgianni, Andrea
Vinacci, Gabriele
Mauri, Marco
Versino, Maurizio
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
title Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
title_full Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
title_fullStr Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
title_full_unstemmed Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
title_short Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
title_sort reversible encephalopathy syndrome (pres) in a covid-19 patient
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312113/
https://www.ncbi.nlm.nih.gov/pubmed/32583053
http://dx.doi.org/10.1007/s00415-020-10001-7
work_keys_str_mv AT princiottacariddilucia reversibleencephalopathysyndromepresinacovid19patient
AT tabaeedamavandipayam reversibleencephalopathysyndromepresinacovid19patient
AT carimatifederico reversibleencephalopathysyndromepresinacovid19patient
AT banfipaola reversibleencephalopathysyndromepresinacovid19patient
AT clemenzialessandro reversibleencephalopathysyndromepresinacovid19patient
AT marellimargherita reversibleencephalopathysyndromepresinacovid19patient
AT giorgianniandrea reversibleencephalopathysyndromepresinacovid19patient
AT vinaccigabriele reversibleencephalopathysyndromepresinacovid19patient
AT maurimarco reversibleencephalopathysyndromepresinacovid19patient
AT versinomaurizio reversibleencephalopathysyndromepresinacovid19patient